The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
DiMe introduces core digital measures set to accelerate drug development for pediatric rare diseases
The Digital Health Measurement Collaborative Community (DATAcc) by the Digital Medicine Society (DiMe) today announced the ...
The FDA and EMA have developed ten guiding principles for AI use in drug development, promoting regulatory alignment and innovation. These principles emphasize a human-centric, risk-based approach, ...
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...
CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results